QCM
RLAY icon

Quantinno Capital Management’s Relay Therapeutics RLAY Stock Holding History

Quantinno Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683K Buy
36,500
+15,312
+72% +$222K ﹤0.01% 2812
2026
Q1 		$211K Buy
21,188
+3,911
+23% +$35K ﹤0.01% 3187
2025
Q4 		$146K Buy
17,277
+4,904
+40% +$35K ﹤0.01% 3099
2025
Q3 		$64.6K Buy
+12,373
New +$47.2K ﹤0.01% 2902

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Quantinno Capital Management's RLAY Position: Q2 2026 in Review

Quantinno Capital Management increased its Relay Therapeutics (RLAY) stake by 72% in Q2 2026, buying an estimated $222K and bringing the position to 36,500 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #2812.

Quantinno Capital Management first reported a position in RLAY in Q3 2025 and has held it in 4 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Quantinno Capital Management held 36,500 shares of Relay Therapeutics worth $683K as of Q2 2026.
  • Quantinno Capital Management bought 15,312 Relay Therapeutics shares in Q2 2026, an estimated $222K.
  • Relay Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2812 holding.
  • Quantinno Capital Management first reported a position in Relay Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.